Cargando…

Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats

The aim of the present study was to determine and compare the degree and duration of corneal anesthesia following topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride treatment in healthy rats. A randomized, blinded, crossover study was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Lelescu, Cristina A., Urdă-Cîmpean, Andrada E., Dumitraș, Daria A., Taulescu, Marian, Mureșan, Cosmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644035/
https://www.ncbi.nlm.nih.gov/pubmed/33151993
http://dx.doi.org/10.1371/journal.pone.0241567
_version_ 1783606383336226816
author Lelescu, Cristina A.
Urdă-Cîmpean, Andrada E.
Dumitraș, Daria A.
Taulescu, Marian
Mureșan, Cosmin
author_facet Lelescu, Cristina A.
Urdă-Cîmpean, Andrada E.
Dumitraș, Daria A.
Taulescu, Marian
Mureșan, Cosmin
author_sort Lelescu, Cristina A.
collection PubMed
description The aim of the present study was to determine and compare the degree and duration of corneal anesthesia following topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride treatment in healthy rats. A randomized, blinded, crossover study was conducted on 20 healthy adult Wistar rats, following complete physical and ophthalmological examination. Baseline corneal touch threshold (CTT) was determined in the central corneal area of both eyes with a Cochet–Bonnet aesthesiometer, in mm filament length. Oxybuprocaine was randomly applied to one eye and 0.9% sterile sodium chloride solution was instilled into the contralateral eye. Subsequent CTT measurements were performed in both eyes 5 minutes after topical application and at 5-minute intervals thereafter for 75-minutes in the anesthetized eye. Following a 2-week washout period, this protocol was repeated with ropivacaine. Quantitative data were summarized as mean ± standard deviation, median and inter-quartile range (Q1–Q3). Repeated measures data were analyzed over time and between treatments using Friedman test and Wilcoxon signed-rank test with Bonferroni adjustment (p < 0.05). Baseline CTT values were 60 mm in all eyes. With oxybuprocaine, CTT values decreased significantly for 65 minutes (0–55 mm; p = 0.002) when compared with baseline; the maximal anesthetic effect (no blink response at 5 mm filament length) was maintained for up to 15 minutes (p < 0.0001). With ropivacaine, CTT values were significantly lower than baseline for 30 minutes (0–55 mm; p = 0.002), with a maximal anesthetic effect recorded at 5 minutes in 18 eyes (p < 0.0001). Oxybuprocaine induced a significantly lower CTT than ropivacaine (p = 0.002) from 10 to 65 minutes following topical application. Both anesthetic agents induced significant corneal anesthesia; however, oxybuprocaine provided a greater and longer anesthetic effect, making it more suitable for potentially painful ophthalmologic procedures.
format Online
Article
Text
id pubmed-7644035
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-76440352020-11-16 Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats Lelescu, Cristina A. Urdă-Cîmpean, Andrada E. Dumitraș, Daria A. Taulescu, Marian Mureșan, Cosmin PLoS One Research Article The aim of the present study was to determine and compare the degree and duration of corneal anesthesia following topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride treatment in healthy rats. A randomized, blinded, crossover study was conducted on 20 healthy adult Wistar rats, following complete physical and ophthalmological examination. Baseline corneal touch threshold (CTT) was determined in the central corneal area of both eyes with a Cochet–Bonnet aesthesiometer, in mm filament length. Oxybuprocaine was randomly applied to one eye and 0.9% sterile sodium chloride solution was instilled into the contralateral eye. Subsequent CTT measurements were performed in both eyes 5 minutes after topical application and at 5-minute intervals thereafter for 75-minutes in the anesthetized eye. Following a 2-week washout period, this protocol was repeated with ropivacaine. Quantitative data were summarized as mean ± standard deviation, median and inter-quartile range (Q1–Q3). Repeated measures data were analyzed over time and between treatments using Friedman test and Wilcoxon signed-rank test with Bonferroni adjustment (p < 0.05). Baseline CTT values were 60 mm in all eyes. With oxybuprocaine, CTT values decreased significantly for 65 minutes (0–55 mm; p = 0.002) when compared with baseline; the maximal anesthetic effect (no blink response at 5 mm filament length) was maintained for up to 15 minutes (p < 0.0001). With ropivacaine, CTT values were significantly lower than baseline for 30 minutes (0–55 mm; p = 0.002), with a maximal anesthetic effect recorded at 5 minutes in 18 eyes (p < 0.0001). Oxybuprocaine induced a significantly lower CTT than ropivacaine (p = 0.002) from 10 to 65 minutes following topical application. Both anesthetic agents induced significant corneal anesthesia; however, oxybuprocaine provided a greater and longer anesthetic effect, making it more suitable for potentially painful ophthalmologic procedures. Public Library of Science 2020-11-05 /pmc/articles/PMC7644035/ /pubmed/33151993 http://dx.doi.org/10.1371/journal.pone.0241567 Text en © 2020 Lelescu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lelescu, Cristina A.
Urdă-Cîmpean, Andrada E.
Dumitraș, Daria A.
Taulescu, Marian
Mureșan, Cosmin
Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
title Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
title_full Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
title_fullStr Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
title_full_unstemmed Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
title_short Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
title_sort effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644035/
https://www.ncbi.nlm.nih.gov/pubmed/33151993
http://dx.doi.org/10.1371/journal.pone.0241567
work_keys_str_mv AT lelescucristinaa effectsoftopicalapplicationof04oxybuprocainehydrochlorideophthalmicsolutionand1ropivacainehydrochlorideoncornealsensitivityinrats
AT urdacimpeanandradae effectsoftopicalapplicationof04oxybuprocainehydrochlorideophthalmicsolutionand1ropivacainehydrochlorideoncornealsensitivityinrats
AT dumitrasdariaa effectsoftopicalapplicationof04oxybuprocainehydrochlorideophthalmicsolutionand1ropivacainehydrochlorideoncornealsensitivityinrats
AT taulescumarian effectsoftopicalapplicationof04oxybuprocainehydrochlorideophthalmicsolutionand1ropivacainehydrochlorideoncornealsensitivityinrats
AT muresancosmin effectsoftopicalapplicationof04oxybuprocainehydrochlorideophthalmicsolutionand1ropivacainehydrochlorideoncornealsensitivityinrats